$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] Prognostic significance of neuronal marker expression in glioblastomas

Child’s nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, v.28 no.11, 2012년, pp.1879 - 1886  

Lee, Kyung-Hwa ,  Kang, Kyung-Joo ,  Moon, Kyung-Sub ,  Jung, Tae-Young ,  Jung, Shin ,  Kim, Jae-Hyoo ,  Kim, Hyung-Seok ,  Lee, Min-Cheol

Abstract AI-Helper 아이콘AI-Helper

Glioblastomas are the most malignant tumors of central nervous system neoplasms and are well known for their biological heterogeneity. Contrary to the putative hypothesis of purely glial differentiation in glioblastomas, they often demonstrate immunopositivity for neuronal markers. However, the sign...

참고문헌 (34)

  1. Mod Pathol B Bodey 4 742 1991 Bodey B, Cosgrove M, Gonzalez-Gomez I, Siegel SE, Martin SE, Gilles FH (1991) Co-expression of four intermediate filament subclasses in childhood glial neoplasms. Mod Pathol 4:742-749 

  2. Am J Surg Pathol M Cosgrove 13 141 1989 10.1097/00000478-198902000-00007 Cosgrove M, Fitzgibbons PL, Sherrod A, Chandrasoma PT, Martin SE (1989) Intermediate filament expression in astrocytic neoplasms. Am J Surg Pathol 13:141-145 

  3. Acta Neuropathol F Dehghani 95 493 1998 10.1007/s004010050830 Dehghani F, Schachenmayr W, Laun A, Korf HW (1998) Prognostic implication of histopathological, immunohistochemical and clinical features of oligodendrogliomas: a study of 89 cases. Acta Neuropathol 95:493-504 

  4. Acta Neuropathol F Dehghani 100 122 2000 10.1007/s004010050003 Dehghani F, Maronde E, Schachenmayr W, Korf HW (2000) Neurofilament H immunoreaction in oligodendrogliomas as demonstrated by a new polyclonal antibody. Acta Neuropathol 100:122-130 

  5. Neuropathol Appl Neurobiol K Donev 36 411 2010 10.1111/j.1365-2990.2010.01078.x Donev K, Scheithauer BW, Rodriguez FJ, Jenkins S (2010) Expression of diagnostic neuronal markers and outcome in glioblastoma. Neuropathol Appl Neurobiol 36:411-421 

  6. Am J Pathol FE Franke 139 67 1991 Franke FE, Schachenmayr W, Osborn M, Altmannsberger M (1991) Unexpected immunoreactivities of intermediate filament antibodies in human brain and brain tumors. Am J Pathol 139:67-79 

  7. Cancer Res WA Freije 64 6503 2004 10.1158/0008-5472.CAN-04-0452 Freije WA, Castro-Vargas FE, Fang Z, Horvath S, Cloughesy T, Liau LM, Mischel PS, Nelson SF (2004) Gene expression profiling of gliomas strongly predicts survival. Cancer Res 64:6503-6510 

  8. Am J Surg Pathol C Giannini 26 479 2002 10.1097/00000478-200204000-00010 Giannini C, Scheithauer BW, Lopes MB, Hirose T, Kros JM, VandenBerg SR (2002) Immunophenotype of pleomorphic xanthoastrocytoma. Am J Surg Pathol 26:479-485 

  9. Acta Neuropathol C Hartmann 120 707 2010 10.1007/s00401-010-0781-z Hartmann C, Hentschel B, Wick W, Capper D, Felsberg J, Simon M, Westphal M, Schackert G, Meyermann R, Pietsch T, Reifenberger G, Weller M, Loeffler M, von Deimling A (2010) Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas. Acta Neuropathol 120:707-718 

  10. Clin Neuropathol J Hirato 13 1 1994 Hirato J, Nakazato Y, Ogawa A (1994) Expression of non-glial intermediate filament proteins in gliomas. Clin Neuropathol 13:1-11 

  11. Arch Pathol Lab Med CD Katsetos 125 613 2001 10.5858/2001-125-0613-ALOTNC Katsetos CD, Del Valle L, Geddes JF, Assimakopoulou M, Legido A, Boyd JC, Balin B, Parikh NA, Maraziotis T, de Chadarevian JP, Varakis JN, Matsas R, Spano A, Frankfurter A, Herman MM, Khalili K (2001) Aberrant localization of the neuronal class III beta-tubulin in astrocytomas. Arch Pathol Lab Med 125:613-624 

  12. Neurol Med Chir (Tokyo) T Kawataki 50 228 2010 10.2176/nmc.50.228 Kawataki T, Sato E, Sato T, Kinouchi H (2010) Anaplastic ganglioglioma with malignant features in both neuronal and glial components-case report. Neurol Med Chir (Tokyo) 50:228-231 

  13. Neuropathology KJ Kim 31 494 2011 10.1111/j.1440-1789.2010.01194.x Kim KJ, Lee KH, Kim HS, Moon KS, Jung TY, Jung S, Lee MC (2011) The presence of stem cell marker-expressing cells is not prognostically significant in glioblastomas. Neuropathology 31:494-502 

  14. P Kleuhues 33 2007 WHO classification of tumours of the central nervous system Kleuhues P, Burger PC, Aldepe KD, Brat DJ, Biernat W, Binger DD, Nakazato Y, Plate KH, Giangaspero F, von Deimling A, Ohgaki H, Cavenee WK (2007) Glioblastoma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) WHO classification of tumours of the central nervous system. IARC, Lyon, pp 33-49 

  15. J Neuropathol Exp Neurol C Labrakakis 56 243 1997 10.1097/00005072-199703000-00003 Labrakakis C, Patt S, Weydt P, Cervos-Navarro J, Meyer R, Kettenmann H (1997) Action potential-generating cells in human glioblastomas. J Neuropathol Exp Neurol 56:243-254 

  16. Acta Neuropathol MB Lopes 91 368 1996 10.1007/s004010050438 Lopes MB, Altermatt HJ, Scheithauer BW, Shepherd CW, VandenBerg SR (1996) Immunohistochemical characterization of subependymal giant cell astrocytomas. Acta Neuropathol 91:368-375 

  17. Arch Pathol Lab Med H Martinez-Diaz 127 1187 2003 10.5858/2003-127-1187-GCGAPX Martinez-Diaz H, Kleinschmidt-DeMasters BK, Powell SZ, Yachnis AT (2003) Giant cell glioblastoma and pleomorphic xanthoastrocytoma show different immunohistochemical profiles for neuronal antigens and p53 but share reactivity for class III beta-tubulin. Arch Pathol Lab Med 127:1187-1191 

  18. Cancer Biol Ther PS Mischel 2 242 2003 10.4161/cbt.2.3.369 Mischel PS, Nelson SF, Cloughesy TF (2003) Molecular analysis of glioblastoma: pathway profiling and its implications for patient therapy. Cancer Biol Ther 2:242-247 

  19. Oncogene PS Mischel 22 2361 2003 10.1038/sj.onc.1206344 Mischel PS, Shai R, Shi T, Horvath S, Lu KV, Choe G, Seligson D, Kremen TJ, Palotie A, Liau LM, Cloughesy TF, Nelson SF (2003) Identification of molecular subtypes of glioblastoma by gene expression profiling. Oncogene 22:2361-2373 

  20. Cancer Res CL Nutt 63 1602 2003 Nutt CL, Mani DR, Betensky RA, Tamayo P, Cairncross JG, Ladd C, Pohl U, Hartmann C, McLaughlin ME, Batchelor TT, Black PM, von Deimling A, Pomeroy SL, Golub TR, Louis DN (2003) Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. Cancer Res 63:1602-1607 

  21. J Child Neurol JR Parker 16 548 2001 10.1177/088307380101600802 Parker JR, Armstrong DL, Strother D, Rudman DM, Dauser RC, Laurent JP, Deyd J, Rouah PE (2001) Antineuronal nuclei immunohistochemical staining patterns in childhood ependymomas. J Child Neurol 16:548-552 

  22. Neuroscience S Patt 71 601 1996 10.1016/0306-4522(95)00468-8 Patt S, Labrakakis C, Bernstein M, Weydt P, Cervos-Navarro J, Nisch G, Kettenmann H (1996) Neuron-like physiological properties of cells from human oligodendroglial tumors. Neuroscience 71:601-611 

  23. J Neuropathol Exp Neurol A Perry 61 947 2002 10.1093/jnen/61.11.947 Perry A, Scheithauer BW, Macaulay RJ, Raffel C, Roth KA, Kros JM (2002) Oligodendrogliomas with neurocytic differentiation. A report of 4 cases with diagnostic and histogenetic implications. J Neuropathol Exp Neurol 61:947-955 

  24. Cancer Cell HS Phillips 9 157 2006 10.1016/j.ccr.2006.02.019 Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, Wu TD, Misra A, Nigro JM, Colman H, Soroceanu L, Williams PM, Modrusan Z, Feuerstein BG, Aldape K (2006) Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9:157-173 

  25. Am J Surg Pathol SZ Powell 20 80 1996 10.1097/00000478-199601000-00009 Powell SZ, Yachnis AT, Rorke LB, Rojiani AM, Eskin TA (1996) Divergent differentiation in pleomorphic xanthoastrocytoma. Evidence for a neuronal element and possible relationship to ganglion cell tumors. Am J Surg Pathol 20:80-85 

  26. Acta Neuropathol FJ Rodriguez 113 313 2007 10.1007/s00401-006-0153-x Rodriguez FJ, Scheithauer BW, Robbins PD, Burger PC, Hessler RB, Perry A, Abell-Aleff PC, Mierau GW (2007) Ependymomas with neuronal differentiation: a morphologic and immunohistochemical spectrum. Acta Neuropathol 113:313-324 

  27. Virchows Arch J Shibahara 447 665 2005 10.1007/s00428-005-1263-x Shibahara J, Fukayama M (2005) Secondary glioblastoma with advanced neuronal immunophenotype. Virchows Arch 447:665-668 

  28. J Neurooncol H Takeuchi 91 33 2009 10.1007/s11060-008-9690-6 Takeuchi H, Kubota T, Kitai R, Matsuda K, Hashimoto N, Sato K (2009) Chromosome 1p and 19q deletions in malignant glioneuronal tumors with oligodendroglioma-like component. J Neurooncol 91:33-38 

  29. Am J Pathol T Tohyama 142 883 1993 Tohyama T, Lee VM, Trojanowski JQ (1993) Co-expression of low molecular weight neurofilament protein and glial fibrillary acidic protein in established human glioma cell lines. Am J Pathol 142:883-892 

  30. Neurosurgery P Varlet 55 1377 2004 10.1227/01.NEU.0000143033.36582.40 Varlet P, Soni D, Miquel C, Roux FX, Meder JF, Chneiweiss H, Daumas-Duport C (2004) New variants of malignant glioneuronal tumors: a clinicopathological study of 40 cases. Neurosurgery 55:1377-1391, discussion 1391-1372 

  31. Histopathology M Vyberg 50 887 2007 10.1111/j.1365-2559.2007.02686.x Vyberg M, Ulhoi BP, Teglbjaerg PS (2007) Neuronal features of oligodendrogliomas-an ultrastructural and immunohistochemical study. Histopathology 50:887-896 

  32. Neuropathol Appl Neurobiol SB Wharton 24 302 1998 10.1046/j.1365-2990.1998.00132.x Wharton SB, Chan KK, Hamilton FA, Anderson JR (1998) Expression of neuronal markers in oligodendrogliomas: an immunohistochemical study. Neuropathol Appl Neurobiol 24:302-308 

  33. Acta Neuropathol SB Wharton 100 695 2000 10.1007/s004010000241 Wharton SB, Lammie GA, Collie DA, Whittle IR (2000) The significance of intratumoural neurones and neuronal differentiation in diffuse gliomas: a case series. Acta Neuropathol 100:695-700 

  34. J Clin Neurosci SB Wharton 9 165 2002 10.1054/jocn.2001.1055 Wharton SB, Chan KK, Whittle IR (2002) Microtubule-associated protein 2 (MAP-2) is expressed in low and high grade diffuse astrocytomas. J Clin Neurosci 9:165-169 

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로